These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 207295)

  • 1. Characterization of beta-adrenoceptor subtype mediating the metabolic actions of salbutamol.
    Berend N; Marlin GE
    Br J Clin Pharmacol; 1978 Mar; 5(3):207-11. PubMed ID: 207295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic actions of intravenous salbutamol and aminophylline singly and in combination.
    Jenkins CR; Marlin GE
    Br J Clin Pharmacol; 1981 Feb; 11(2):197-201. PubMed ID: 7011349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practolol inhibition of some salbutamol-induced metabolic and hormonal responses.
    Massara F; Martina V; Fassio V; Sapelli S; Molinatti G
    Acta Diabetol Lat; 1977; 14(5-6):257-62. PubMed ID: 207065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of salbutamol-induced hypokalaemia.
    Whyte KF; Addis GJ; Whitesmith R; Reid JL
    Br J Clin Pharmacol; 1987 Jan; 23(1):65-71. PubMed ID: 3545273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nature of the beta-adrenoreceptor controlling plasma renin activity in man.
    Johnson BF; Smith IK; LaBrooy J; Bye C
    Clin Sci Mol Med Suppl; 1976 Dec; 3():113s-115s. PubMed ID: 192510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracoronary injections of salbutamol demonstrate the presence of functional beta 2-adrenoceptors in the human heart.
    Hall JA; Petch MC; Brown MJ
    Circ Res; 1989 Sep; 65(3):546-53. PubMed ID: 2548759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenoceptors in the human dorsal hand vein, and the effects of propranolol and practolol on venous sensitivity to noradrenaline.
    White CB; Udwadia BP
    Br J Clin Pharmacol; 1975 Apr; 2(2):99-105. PubMed ID: 186090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the beta2-adrenoceptor selectivity of rimiterol, salbutamol and isoprenaline by the intravenous route in man.
    Marlin GE; Turner P
    Br J Clin Pharmacol; 1975 Feb; 2(1):41-8. PubMed ID: 10940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the effects of salbutamol by propranolol and atenolol.
    Minton NA; Baird AR; Henry JA
    Eur J Clin Pharmacol; 1989; 36(5):449-53. PubMed ID: 2753063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine.
    Vincent HH; Boomsma F; Man in't Veld AJ; Derkx FH; Wenting GJ; Schalekamp MA
    J Cardiovasc Pharmacol; 1984; 6(1):107-14. PubMed ID: 6199591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and hormonal effects of preferential beta 1 and beta 2-adrenoceptor stimulation in man.
    Tantucci C; Santeusanio F; Beschi M; Castellano M; Sorbini C; Grassi V
    J Endocrinol Invest; 1988 Apr; 11(4):279-87. PubMed ID: 2842389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some metabolic and hormonal effects of salbutamol in man.
    Massara F; Fassio V; Camanni F; Martina V; Molinatti G
    Acta Diabetol Lat; 1976; 13(3-4):146-53. PubMed ID: 1020612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic response to the activation of the beta-adrenergic receptor by salbutamol is amplified by acylated ghrelin.
    St-Pierre DH; Benso A; Gramaglia E; Prodam F; Lucatello B; Ramella-Gigliardi V; Olivetti I; Tomelini M; Broglio F
    J Endocrinol Invest; 2010 Jun; 33(6):363-7. PubMed ID: 20631491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of beta1- and beta2-adrenoceptors in the inhibition of gastric acid secretion in the dog.
    Daly MJ; Long JM; Stables R
    Br J Pharmacol; 1978 Sep; 64(1):153-7. PubMed ID: 212150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the metabolic responses to inhaled salbutamol in the measurement of beta 2-adrenoceptor blockade.
    Lipworth BJ; McFarlane LC; Coutie WJ; McDevitt DG
    Eur J Clin Pharmacol; 1989; 37(3):297-300. PubMed ID: 2575521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of bronchial beta-adrenoceptor blockade in man.
    Gribbin HR; Baldwin CJ; Tattersfield AE
    Br J Clin Pharmacol; 1979 Jun; 7(6):551-6. PubMed ID: 37867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and cardiovascular effects of salbutamol in atopic subjects with and without asthma.
    Kallenbach J; Joffe BI; Zwi S; Seftel HC
    Scand J Respir Dis; 1979 Feb; 60(1):44-8. PubMed ID: 220703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The uterine and cardiovascular effects of salbutamol and practolol during labour.
    McDevitt DG; Wallace RJ; Roberts A; Whitfield CR
    Br J Obstet Gynaecol; 1975 Jun; 82(6):442-8. PubMed ID: 1138834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral platelet count in response to salbutamol before and after adrenergic beta-receptor blockade.
    Fredén K; Olsson LB; Vilén L; Kutti J
    Acta Haematol; 1978; 60(5):310-5. PubMed ID: 30249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.